Table 4.
Variable | Unadjusted odds ratio (95% CI) | P‐value | Adjusted odds ratio (95% CI) | P‐value |
---|---|---|---|---|
Scenario 1 | ||||
Age (years)* | 1.06 (1.02–1.09) | <0.001 | 1.05 (1.02–1.09) | 0.002 |
50–59† | 1.00 | 1.00 | ||
60–70 | 1.93 (1.32–2.82) | 1.85 (1.25–2.73) | ||
Educational qualifications | ||||
Without SC | 1.77 (1.01–3.11) | 0.009 | 1.43 (0.80–2.55) | 0.03 |
SC/TAFE/HSC | 1.89 (1.23–2.91) | 1.78 (1.15–2.74) | ||
University qualification† | 1.00 | 1.00 | ||
Scenario 2 | ||||
Age (years) | 1.04 (1.01–1.08) | 0.01 | NA | NA |
50–59† | 1.00 | |||
60–70 | 1.56 (1.07–2.29) | |||
Scenario 3 | ||||
Educational qualifications | ||||
Left before SC | 1.69 (0.99–2.88) | 0.02 | 1.57 (0.90–2.75) | 0.03 |
SC/HSC/TAFE | 1.74 (1.16–2.61) | 1.71 (1.14–2.57) | ||
University degree† | 1.00 | 1.00 | ||
Employment status | ||||
Not employed | 1.67 (1.13–2.45) | 0.01 | 1.60 (1.07–2.39) | 0.02 |
Employed† | 1.00 | 1.00 | ||
Current smoker | ||||
Yes† | 1.00 | 0.09 | 1.00 | 0.051 |
No | 1.55 (0.93–2.59) | 1.67 (0.99–2.82) | ||
Scenario 4 | ||||
Age (years) | 1.05 (1.02–1.09) | 0.002 | 1.05 (1.01–1.08) | 0.02 |
50–59† | 1.00 | 1.00 | ||
60–70 | 1.79 (1.22–2.62) | 1.68 (1.14–2.48) | ||
Self‐reported health status | ||||
Excellent/good† | 1.00 | 0.006 | 1.00 | 0.007 |
Fair/poor | 1.81 (1.19–2.74) | 1.66 (1.08–2.53) | ||
Scenario 5 | ||||
Age (years) | 1.07 (1.03–1.11) | <0.001 | 1.07 (1.03–1.10) | 0.001 |
50–59† | 1.00 | 1.00 | ||
60–70 | 2.23 (1.45–3.42) | 2.13 (1.38–3.29) | ||
Has ever had heart attack or stroke | ||||
Yes | 2.35 (1.22–4.52) | 0.01 | 1.98 (1.01–3.86) | 0.052 |
No† | 1.00 | 1.00 |
*Age was modeled as a continuous variable. Age is also presented as a categorical variable to facilitate interpretation of the effect age has on the outcomes’.
†Referent group.
Scenario 1, lack of evidence underpinning efficacy of screening; scenario 2, risk of detecting indolent cancer; scenario 3, lifetime risk of dying from cancer; scenario 4: lack of expert consensus on the efficacy of early detection; scenario 5, uncertainty of benefit from treatment and risk of developing side‐effects from treatment.